TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.

by Mariana Maschietto, Richard D Williams, Tasnim Chagtai, Sergey D Popov, Neil J Sebire, Gordan Vujanic, Elizabeth Perlman, James R Anderson, Paul Grundy, Jeffrey S Dome, Kathy Pritchard-Jones
Published 2014-01-01

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors

by Taryn D. Treger, Tasnim Chagtai, Robert Butcher, George D. Cresswell, Reem Al-Saadi, Jesper Brok, Richard D. Williams, Chrissy Roberts, Nicholas M. Luscombe, Kathy Pritchard Jones, William Mifsud
Published 2018-12-01

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications

by George D. Cresswell, John R. Apps, Tasnim Chagtai, Borbala Mifsud, Christopher C. Bentley, Mariana Maschietto, Sergey D. Popov, Mark E. Weeks, Øystein E. Olsen, Neil J. Sebire, Kathy Pritchard-Jones, Nicholas M. Luscombe, Richard D. Williams, William Mifsud
Published 2016-07-01